References From Anticancer Drugs

1. Almond, J. B., and Cohen, G. M. (2002). Leukemia 26, 433.

2. Neefjes, J., and Dantuma, M. P. (2004). Nat. Rev. Drug Discov. 3, 58.

4. Myung, J., Kim, K. B., and Crews, C. M. (2001). Med. Res. Rev. 21, 245.

5. García-Echeverría, C. (2002). Mini-Rev. Med. Chem. 2, 247.

6. Boccadoro, M., Morgan, G., and Cavenagh, J. (2005). Cancer Cell Int. 5,18.

7. Paramore, A., and Frantz, S. (2003). Nat. Rev. Drug Discov. 2, 611.

9. Groll, M., Kim, K. B., Kairies, N., Huber, R., and Crews, C. M. (2000). J. Am. Chem. Soc. 122,1237.

10. Adams, J., Behnke, M., Chen, S., Cruickshank, A. A., Dick, L. R., Grenier, L., Klunder, J. M., Ma, Y. T., Plamondon, L., and Stein, R. L. (1998). Bioorg. Med. Chem. Lett. 8,333.

11. Gourley, M., and Williamdon, J. S. (2000). Curr. Pharm. Des. 6,417.

12. Dhanabal, M., Jeffers, M., and LaRochelle, W. J. (2005). Curr. Med. Chem. Anticancer Agents 5,115.

14. Borkakoti, N. (2004). Biochem. Soc. Trans. 32,17.

15. Cross, J. B., Duca, J. S., Kaminski, J. J., and Madison, V. S. (2002). J. Am. Chem. Soc. 124,1004.

16. Botos, I., Scapozza, L., Zhang, D., Liotta, L. A., and Meyer, E. F. (1996). Proc. Nat. Acad. Sci. USA 93, 2749.

17. Coussens, L. M., Fingleton, B., and Matrisian, L. M. (2002). Science 295, 2387.

18. Bissett, D., O'Byrne, K. J., von Pawel, J., Gatzemeier, U., Price, A., Nicolson, M., Mercier, R., Mazabel, E., Penning, C., Zhang, M. H., Collier, M. A., and Shepherd, F. A. (2005). J. Clin. Oncol. 23, 842.

19. Gingras, D., Boivin, D., Deckers, C., Gendron, S., Barthomeuf, C., and Beliveau, R. (2003). Anticancer Drugs 14, 91.

20. Okada, Y., Yamada, S., Toyoshima, M., Dong, J., Nakajima, M., and Sugahara, K. (2002). J. Biol. Chem. 277, 42488.

21. Hulett, M. D., Hornby, J. R., Ohms, S. J., Zuegg, J., Freeman, C., Gready, J. E., and Parish, C. R. (2000). Biochemistry 39,15659.

22. Ferro, V., Hammond, E., and Fairweather, J. K. (2004). Mini-Rev. Med. Chem. 4, 693.

23. Miao, H.-Q., Liu, H., Navarro, E., Kussie, P., and Zhu, Z. (2006). Curr. Med. Chem. 13, 2101.

24. Basche, M., Gustafson, D. L., Holden, S. N., O'Bryant, C. L., Gore, L., Witta, S., Schultz, M. K., Morrow, M., Levin, A., Creese, B. R., Kangas, M., Roberts, K., et al. (2006). Clin. Cancer Res. 12,5471.

25. Marchetti, D., Reiland, J., Erwin, B., and Roy, M. (2003). Int. J. Cancer 104,167.

26. Bols, M., Lillelund, V. H., Jensen, H. H., and Liang, X. (2002). Chem. Rev. 102, 515.

27. Kulke, M. H., Bergsland, E. K., Ryan, D. P., Enzinger, P. C., Lynch, T. J., Zhu, A. X., Meyerhardt, J. A., Heymach, J. V., Fogler, W. E., Sidor, C., Michelini, A., Kinsella, K., Venook, A. P., and Fuchs, C. S. (2006). J. Clin. Oncol. 24, 3555.

28. http://www.clinicaltrials.gov/ct/gui/show/NCT00049790; jsessionid=91EE48B7C2F7D935B96F 12E31D5609E3?order=1

29. Haviv, F., Bradley, M. F., Kalvin, D. M., Schneider, A. J., Davidson, D. J., Majest, S. M., McKay, L. M., Haskell, C. J., Bell, R. L., Nguyen, B., Marsh, K. C., Surber, B. W., et al. (2005). J. Med. Chem. 48, 2838.

30. De Vos, F. Y., Hoekstra, R., Eskens, F. A. L. M., De Vries, E. G., VanderGaast, A., Groen, H. J. M., Knight, R., Humerickhouse, R. A., Gietema, J. A., and Verweij, J. (2004). J. Clin. Oncol. 22(14S), 3077.

32. Featherstone, J., and Griffiths, S. (2002). Nat. Rev. Drug Discov. 1, 413.

33. Serini, G., Valdembri, B., and Bussolino, F. (2006). Exp. Cell Res. 312, 651.

34. Kumar, C. C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T., Varner, J., Liu, M., Smith, E. M., Neustadt, B., Presta, M., and Armstrong, L. (2001). Cancer Res. 61, 2232.

35. Gutheil, J. C., Campbell, T. N., Pierce, P. R., Watkins, J. D., Huse, W. D., Bodkin, D. J., and Cheresh, D. A. (2000). Clin. Cancer Res. 6, 3056.

36. Akhter, S., Nath, S. K., Tse, C. M., Williams, J., Zasloff, M., and Donowitz, M. (1999). Am. J. Physiol. Cell Physiol. 45, C136.

37. Pietras, R. J., and Weinberg, O. K. (2005). Evid. Based Complement. Alternat. Med. 2,49.

38. Bauer, K. S., Dixon, S. C., and Figg, W. D. (1998). Biochem. Pharmacol 55,1827.

39. Kumar, S., Witzig, T. E., Dispenzieri, A., Lacy, M. Q., Wellik, L. E., Fonseca, R., Lust, J. A., Gertz, M. A., Kyle, R. A., Greipp, P. R., and Rajkumar, S. V. (2004). Leukemia 18, 624.

40. García-Sanz, R., Gonzaiez-Porras, J. R., Hernandez, J. M., Polo-Zarzuela, M., Sureda, A., Barrenetxea, C., Palomera, L., Lopez, R., Grande-García, C., Alegre, A., Vargas-Pabon, M., Gutierrez, O. N., et al. (2004). Leukemia 18, 856.

41. Saunders, G. (2005). J. Oncol. Pharm. Pract. 11, 83.

42. Richardson, P., and Anderson, K. (2004). J. Clin. Oncol. 22,3212.

43. Dredge, K., Dalgleish, A. G., and Marriott, J. B. (2003). Anticancer Drugs 14,331.

44. Maier, S. K., and Hammond, J. M. (2006). Ann. Pharmacother. 40, 286.

45. Schey, S. A., Fields, P., Bartlett, J. B., Clarke, I. A., Ashan, G., Knight, R. D., Streetly, M., and Dalgleish, A. G. (2004). J. Clin. Oncol. 22, 3269.

46. Teo, S. K., Chen, Y., Muller, G. W., Chen, R. S., Thomas, S. D., Stirling, D. I., and Chandula, R. S. (2003). Chirality 15, 348.

47. Liekens, S., De Clerq, E., and Neyts, J. (2001). Biochem. Pharmacol. 61, 253.

48. Liu, S., Widom, J., Kemp, C. W., Crews, C. M., and Clardy, J. (1998). Science 282,1324.

49. Wernert, N., Stamjek, A., Kiriakidis, S., Hügel, A., Jha, H. C., Mazitschek, R., and Giannis, A. (1999). Angew. Chem. Int. Ed. 38, 3228.

50. Connell, R. D., and Beebe, J. S. (2001). Expert Opin. Ther. Patents 11, 77.

51. Yoo, C. B., and Jones, P. A. (2006). Nat. Rev. Drug Discov. 5,37.

52. Yoo, C. B., Cheng, J. C., and Jones, P. A. (2004). Biochem. Soc. Trans. 32, 910.

53. Issa, J.-P., and Kantarjian, H. (2005). Nat. Rev. Drug Discov. 4, S6.

54. Kaminskas, E., Farrell, A. T., Abraham, S., Baird, A., Hsieh, L.-S., Lee, S.-L., Leighton, J. K., Patel, H., Rahman, A., Sridhara, R., Wang, Y.-C., and Pazdur, R. (2005). Clin. Cancer Res. 11, 3604.

55. Kaminskas, E., Farrell, A. T., Wang, Y.-C., Sridhara, R., and Padzur, R. (2005). Oncologist 10, 176.

56. Kuykendall, J. R. (2005). Ann. Pharmacother. 39,1700.

57. Issa, J.-P. J., Gharibyan, V., Cortes, J., Jelinek, J., Morris, G., Verstovsek, S., Talpaz, M., Garcia-Manero, G., and Kantarjian, H. M. (2005). J. Clin. Oncol. 23, 3948.

58. http://clinicalstudies.info.nih.gov/detail/A_2006-C-0221.html

59. Dhingra, H. M., Murphy, W. K., Winn, R. J., Raber, N. M., and Hong, W. K. (2004). Invest. New Drugs 9, 69.

60. Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., and Selker, E. A. (2003). J. Natl. Cancer Inst. 95, 399.

61. Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., and Hornby, D. P. (2002). J. Mol. Biol. 321, 591.

62. Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., and Jones, P. A. (2004). Cancer Cell 6, 151.

63. Jeong, L. S., Buenger, G., McCormack, J. J., Cooney, D. A., Hao, Z., and Marquez, V. E. (1998). J. Med. Chem. 41, 2572.

64. Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., and Gerwick, W. H. (2005). Mol. Cancer Ther. 4, 333.

65. Fang, M. Z., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W., and Yang, C. S. (2003). Cancer Res. 63, 7563.

66. Brueckner, B., García Boy, R., Siedlecki, P., Musch, T., Kliem, H. C., Zielenkiewicz, P., Suhai, S., Wiessler, M., and Lyko, F. (2005). Cancer Res. 65, 6305.

67. http://clinicaltrials.gov/ct/show/NCT00324220

68. Siedlecki, P., García Boy, R., Comagic, S., Schirrmacher, R., Wiessler, M., Zielenkiewicz, P., Suhai, S., and Lykoc, F. (2003). Biochem. Biophys. Res. Commun. 306,558.

69. Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., and Kelly, W. K. (2001). Nat. Rev. Cancer 1, 194.

70. Johnstone, R. W. (2002). Nat. Rev. Drug Discov. 1, 287.

72. Moradei, O., Maroun, C. R., Paquin, I., and Vaisburg, A. (2005). Curr. Med. Chem. Anticancer Agents 5, 529-560.

73. Carey, N., and La Thangue, N. B. (2006). Curr. Opin. Pharmacol. 6, 369.

74. Flinnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., and Pavletich, N. P. (1999). Nature 401,188.

75. Khanwani, S. L., Edelman, M. J., and Tait, N. (2001). Proc. Am. Soc. Clin. Oncol. 20, 86a.

76. Raffoux, E., Chaibi, P., Dombret, H., and Degos, L. (2005). Haematologica 90, 986.

77. Vigushin, D. M., Ali, S., Pace, P. E., Mirsaidi, N., Ito, K., Adcock, I., and Coombes, R. C. (2001). Clin. Cancer Res. 7, 971.

78. Duvic, M., Talpur, R., Ni, X., Zhang, C., Hazarika, P., Kelly, C., Chiao, J. H., Reilly, J. F., Ricker, J. L., Richon, V. N., and Frankel, S. (2007). Blood 109,31.

79. http://www.clinicaltrials.gov/ct/show/NCT00042900; jsessionid=47CCC05C87B745FACD2295 C56507E1A6?order=48

80. Giles, F., Fischer, T., Cortes, J., Garcia-Manero, G., Beck, J., Ravandi, F., Masson, E., Rae, P., Laird, G., Sharma, S., Kantarjian, H., Dugan, M., Albitar, M., and Bhalla, K. (2006). Clin. Cancer Res. 12,4628.

81. Byrd, J. C., Marcucci, G., Parthun, M. R., Xiao, J. J., Klisovic, R. B., Moran, M., Lin, T. S., Liu, S., Sklenar, A. R., Davis, M. E., Lucas, M. E., Fischer, B., et al. (2005). Blood 105, 959.

82. Furamai, R., Matsuyama, A., Kobashi, N., Lee, K.-H., Nishiyama, M., Nakajima, H., Tanaka, A., Komatsu, Y., Nishino, N., Yoshida, M., and Horinouchi, S. (2002). Cancer Res. 62,4916.

83. Furamai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., and Horinouchi, S. (2001). Proc. Natl. Acad. Sci. USA 98, 87.

84. Kwon, S. H., Ahn, S. H., Kim, Y. K., Bae, G.-U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y.-W., Lee, H.-W., and Han, J. W. (2002). J. Biol. Chem. 277,2073.

85. Komatsu, Y., Tomizaki, K.-Y., Tsukamoto, M., Kato, T., Nishino, N., Sato, S., Yamori, T., Tsuruo, T., Furumai, R., Yoshida, M., Horinouchi, S., and Hayashi, H. (2001). Cancer Res. 61,4459.

86. http://www.clinicaltrials.gov/ct/show/NCT00101179

87. Undevia, S. D., Kindler, H. L., Janisch, L., Olson, S. C., Schilsky, R. L., Vogelzang, N. J., Kimmel, K. A., Macek, T. A., and Ratain, M. J. (2004). Ann. Oncol. 15,1705.

88. http://www.clinicaltrials.gov/ct/show/NCT00374296; jsessionid=92563A45C8B57CDD90D1719 43745C815?order=8

89. Koutsodontis, G., and Kardassis, D. (2004). Oncogene 23, 9190.

90. Neidle, S., and Parkinson, G. (2002). Nat. Rev. Drug Discov. 1,383.

91. Mergny, J.-L., Riou, J.-F., Mailliet, P., Teulade-Fichou, M.-P., and Gilson, E. (2002). Nucl. Acid Res. 30, 839.

92. Cunningham, A. P., Love, W. K., Zhang, R. W., Andrews, L. G., and Tollefsbol, T. O. (2006). Curr. Med. Chem. 13, 2875.

94. Ascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kaufmann, I., Garinchesa, P., Rettig, W. J., Damm, K., and Schnapp, A. (2002). J. Biol. Chem. 277,15566.

95. Herbert, B. S., Gellert, G. C., Hochreiter, A., Pongracz, K., Wright, W. E., Zielinska, D., Chin, A. C., Harley, C. B., Shay, J. W., and Gryaznov, S. M. (2005). Oncogene 24, 5262.

96. Berthet, N., Boturyn, D., and Constant, J.-F. (1999). Expert Opin. Ther. Patents 9,401.

97. Takebayashi, K., Pourquier, P., Zimonjic, D. B., Nakayama, K., Emmert, S., Ueda, T., Urasaki, Y., Kanzaki, A., Akiyama, S., Popescu, N., Kraemer, K. H., and Pommier, Y. (2001). Nat. Med. 7, 961.

98. Zewail-Foote, M., Ven-Shun, L., Kohn, H., Bearss, D., Guzman, M., and Hurley, L. H. (2001). Chem. Biol. 135,1.

99. Damia, G., Silvestri, S., Carrassa, L., Filiberti, L., Faircloth, G. T., Liberi, G., Foiani, M., and D'incalci, M. (2001). Int. J. Cancer 92, 583.

100. Khuri, F. R., and Kurie, J. M. (2000). Clin. Cancer Res. 6,1607.

101. Segota, E., and Bukowski, R. M. (2004). Cleve. Clin. J. Med. 71,551.

102. http://clinicaltrials-nccs.nlm.nih.gov/ct/show/NCT00401570; jsessionid=A8186BC084BE2C690 ACBDDE0B44F8330?order=25

103. Posey, J. A., Khazaeli, M. B., DelGrosso, A., Saleh, M. N., Lin, C. Y., Huse, W., and LoBuglio, A. F. (2001). Cancer Biother. Radiopharm. 16,125.

104. Buchsbaum, D. J., and Curiel, D. T. (2001). Cancer Biother. Radiopharmacol. 16, 275.

105. Bladon, C. M. (2002). In ''Pharmaceutical Chemistry: Therapeutic Aspects of Biomacromolecules,'' chapter 5, Wiley, Chichester.

This page intentionally left blank

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment